Results 51 to 60 of about 78,579 (196)

Method Development for Estimation of Azelnidipine and S (-) Metoprolol Succinate in Tablets by UV Spectrophotometry and HPLC Using Student’s T-Test

Indian Journal of Pharmaceutical Education and Research
Introduction: Azelnidipine a calcium channel blocker belongs to BCS class II and S (-) Metoprolol Succinate belongs to BCS class I. Rationale: Calcium is responsible for inducing smooth muscle contraction.
Saylee Ganorkar, Aditya Bhavsar, Rahul Khiste   +2 more
semanticscholar   +1 more source

First Report on Atrial Leadless Pacing in a Lateral Tunnel Fontan Patient

Journal of Cardiovascular Electrophysiology, Volume 37, Issue 3, Page 539-543, March 2026.
ABSTRACT Introduction No reports on atrial leadless pacing have been demonstrated in patients with the Fontan palliation. We present the case of a patient with a Lateral tunnel Fontan palliation with leadless pacing system for symptomatic bradycardia in the setting of sinus node dysfunction. Methods After internal review board approval, a retrospective
Daniel Cortez, Omar Abu Anza, Mohammad Alnoor   +2 more
wiley   +1 more source

Análisis de costo efectividad del uso de metoprolol succinato en el tratamiento de la hipertensión arterial y la falla cardiaca en Colombia Analysis of cost effectiveness of the use of metoprolol succinate in the treatment of hypertension and heart failure in Colombia

Revista Colombiana de Cardiología, 2012
Objetivo: realizar una evaluación de costo-efectividad del uso de metoprolol succinato frente a metoprolol tartrato y carvedilol en el tratamiento de pacientes con insuficiencia cardiaca congestiva e hipertensión arterial en Colombia, desde la ...
Martín Romero, Carlos H Arango
doaj  

The High Price of Interrupted Follow‐Up: Catastrophic Progression of Homozygous Familial Hypercholesterolemia—A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Familial hypercholesterolemia (FH) is the most common monogenic lipid disorder, primarily resulting from mutations in LDLR, APOB, and PCSK9 genes. These mutations cause persistently high levels of low‐density lipoprotein cholesterol (LDL‐C), predisposing affected individuals to premature atherosclerotic cardiovascular disease (ASCVD ...
Parham Dastjerdi, Mahdieh Aghababaei, Reza Nikfar, Maryam Aghakouchakzadeh, Reza Mohseni‐Badalabadi, Kaveh Hosseini   +5 more
wiley   +1 more source

BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST

Рациональная фармакотерапия в кардиологии, 2016
Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed. Results of the basic clinical trials with BB (LIFE, ASCOT, etc.) are analyzed. The role of sympathetic system in different stages of cardiovascular continuum as
L. N. Malaj
doaj   +1 more source

Multi‐Modality Imaging Evaluation and Optimal Management of Complex Coronary Artery Aneurysms

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Coronary artery aneurysms (CAA) present variably and require multimodal imaging—catheterization, CTCA, stress echocardiography among others—for diagnosis. Management, individualized per patient, includes medical, percutaneous, or surgical approaches.
Aro Daniela Arockiam, Sharmeen Sorathia, Rishabh Khurana, Ankit Agrawal, Elio Haroun, Alexandra Hall, Christine Jellis, Shinya Unai, Tom Kai Ming Wang   +8 more
wiley   +1 more source

Effect of hesperetin on the pharmacokinetics of metoprolol succinate in rats

Future Journal of Pharmaceutical Sciences, 2023
Background Metoprolol is a substrate of CYP3A4, 2B6, CYP2D6, CYP2C9, and p-glycoprotein (p-gp). Hesperetin was reported as an inhibitor of cytochrome P-450 (CYP) enzymes and p-gp. The objective of this study was to investigate the effect of hesperetin on
Ravindra Babu Pingili, Sridhar Vemulapalli, Surya Sandeep Mullapudi, Vijaya R. Dirisala, Harsha Sai Chanumolu, Naveen Babu Kilaru   +5 more
doaj   +1 more source

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released presentation (Betaloc ZOK, AstraZeneca) for achievement of target level of heart rate (HR) in patients with stable course of ischemic heart disease (IHD ...
S. N. Tolpygina, S. Y. Martsevich
doaj   +1 more source

Design and characterization of controlled release tablet of metoprolol

Journal of Pharmacy and Bioallied Sciences, 2012
Metoprolol succinate is a selective beta-adrenergic receptor blocker useful in treatment of hypertension, angina and heart failure. The purpose of the present work was to design and evaluate controlled release matrix type tablet of Metoprolo succinate ...
Gautam Singhvi, Ravi Ukawala, Harish Dhoot, Suresh Jain   +3 more
doaj   +1 more source

Clozapine‐Related Arterial Hypertension in a Man With Resistant Schizophrenia: A Case Report

Case Reports in Medicine, Volume 2026, Issue 1, 2026.
Introduction Clozapine is an atypical antipsychotic widely used in treatment‐resistant schizophrenia. While it is commonly associated with orthostatic hypotension, clozapine‐induced hypertension is a rare but reported adverse effect with unclear mechanisms.
Salah-Eddine El Jabiry, Hajar benfekrane, Jouhayna Soudani, Souhaila Koualla, Marouane Najmi, Fatima El Ghazouani, Bouchra Oneib, Wang Chun Kwok   +7 more
wiley   +1 more source